Safety, tolerability, and effectiveness of oxymorphone extended release for moderate to severe osteoarthritis pain: a one-year study.
about
Oral or transdermal opioids for osteoarthritis of the knee or hipLong-term opioid management for chronic noncancer painLong-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety?Systematic literature review and meta-analysis of the efficacy and safety of prescription opioids, including abuse-deterrent formulations, in non-cancer pain managementIncreased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data.Bioequivalence of oxymorphone extended release and crush-resistant oxymorphone extended release.Oral oxymorphone for pain management.Oral extended-release oxymorphone: a new choice for chronic pain relief.Review of oral oxymorphone in the management of pain.What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review.Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant painOpioids in chronic noncancer pain.Opioid therapy for osteoarthritis and chronic low back pain.Chronic pain treatment with opioid analgesics: benefits versus harms of long-term therapy.Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity.Providing chronic pain management in the "Fifth Vital Sign" Era: Historical and treatment perspectives on a modern-day medical dilemma.Adherence and long-term effect of oxycodone/paracetamol in chronic noncancer pain: a retrospective study.Update on extended-release opioids in pain management.Efficacy of opioids versus placebo in chronic pain: a systematic review and meta-analysis of enriched enrollment randomized withdrawal trials.
P2860
Q24240601-BD2042DD-8886-44DF-A5FD-F55E346881F5Q24240811-DC914F2D-5400-431C-87A5-A8C9194B0AD2Q24598228-406CC5C8-6A0E-4401-A019-5B6356845A87Q26853312-D9C8A7C3-038A-49F6-984B-AABFBDCD1D77Q33516685-FB039C79-00FF-41BB-933D-F0F385FFD689Q35596682-ABAA5441-9EF1-40DD-A060-24A1F05E23DCQ36862314-45D4AD8A-1D3E-4661-83B7-17EC5881B918Q36895853-09DC0334-15A6-40DC-B611-F5A8E428E063Q37052760-0BF94B70-02CC-4F2A-8006-35A8261BEF33Q37167680-6026AD28-6476-4E0E-9525-9F488BC41993Q37593370-05A9C9FA-5ECB-41FB-84A6-22D68D33FCC7Q37737304-5DC819CC-20D3-4971-A14D-F710E92F0C39Q37810414-28EC833B-CB5D-4523-AF39-144C9C7B1D02Q38157029-18C0C590-A5B8-4540-B839-7016CBD56B38Q38434869-44B6947F-5741-49F7-B2C6-012CAF638D49Q38737065-EC934D25-C0F0-4AE3-BC23-1867C00B94A7Q39267390-1033FCAE-411F-42C4-943B-DD4545DBF812Q43062349-C56A3783-17F9-4412-ACB8-1F813C098A08Q54996859-0357DAAA-D4A2-4597-B223-BE7C6FFC86B2
P2860
Safety, tolerability, and effectiveness of oxymorphone extended release for moderate to severe osteoarthritis pain: a one-year study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Safety, tolerability, and effe ...... hritis pain: a one-year study.
@en
Safety, tolerability, and effe ...... hritis pain: a one-year study.
@nl
type
label
Safety, tolerability, and effe ...... hritis pain: a one-year study.
@en
Safety, tolerability, and effe ...... hritis pain: a one-year study.
@nl
prefLabel
Safety, tolerability, and effe ...... hritis pain: a one-year study.
@en
Safety, tolerability, and effe ...... hritis pain: a one-year study.
@nl
P1476
Safety, tolerability, and effe ...... hritis pain: a one-year study.
@en
P2093
Harris McIlwain
Harry Ahdieh
P304
P356
10.1097/01.MJT.0000139442.65914.F9
P577
2005-03-01T00:00:00Z